137 related articles for article (PubMed ID: 23832106)
41. Chronic food restriction differentially affects NPY mRNA level in neurons of the hypothalamus and in neurons that innervate liver.
Sucajtys-Szulc E; Goyke E; Korczynska J; Stelmanska E; Rutkowski B; Swierczynski J
Neurosci Lett; 2008 Mar; 433(3):174-7. PubMed ID: 18242853
[TBL] [Abstract][Full Text] [Related]
42. Postnatal expression patterns and polymorphism analysis of the bovine myocyte enhancer factor 2C (Mef2C) gene.
Juszczuk-Kubiak E; Wicińska K; Starzyński RR
Meat Sci; 2014 Dec; 98(4):753-8. PubMed ID: 25108515
[TBL] [Abstract][Full Text] [Related]
43. 5q14.3 deletion manifesting as mitochondrial disease and autism: case report.
Ezugha H; Goldenthal M; Valencia I; Anderson CE; Legido A; Marks H
J Child Neurol; 2010 Oct; 25(10):1232-5. PubMed ID: 20179003
[TBL] [Abstract][Full Text] [Related]
44. Distribution of NPY receptors in the hypothalamus.
Fetissov SO; Kopp J; Hökfelt T
Neuropeptides; 2004 Aug; 38(4):175-88. PubMed ID: 15337370
[TBL] [Abstract][Full Text] [Related]
45. Direct and indirect modulation of neuropeptide Y gene expression in response to hypoglycemia in rat arcuate nucleus.
Watanabe M; Arima H; Fukushima K; Goto M; Shimizu H; Hayashi M; Banno R; Sato I; Ozaki N; Nagasaki H; Oiso Y
FEBS Lett; 2008 Oct; 582(25-26):3632-8. PubMed ID: 18835268
[TBL] [Abstract][Full Text] [Related]
46. Myocyte Enhancer Factor 2C as a New Player in Human Breast Cancer Brain Metastases.
Galego S; Kauppila LA; Malhó R; Pimentel J; Brito MA
Cells; 2021 Feb; 10(2):. PubMed ID: 33673112
[TBL] [Abstract][Full Text] [Related]
47. Myocyte-specific enhancer binding factor 2C expression in fetal mouse brain development.
Leifer D; Li YL; Wehr K
J Mol Neurosci; 1997 Apr; 8(2):131-43. PubMed ID: 9188042
[TBL] [Abstract][Full Text] [Related]
48. Experience-Dependent and Differential Regulation of Local and Long-Range Excitatory Neocortical Circuits by Postsynaptic Mef2c.
Rajkovich KE; Loerwald KW; Hale CF; Hess CT; Gibson JR; Huber KM
Neuron; 2017 Jan; 93(1):48-56. PubMed ID: 27989458
[TBL] [Abstract][Full Text] [Related]
49. [Clinical phenotype and genetic analysis of a case of 5q14.3 microdeletion syndrome].
Xu X; Li H; Zhang L; Lu F; Tang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Nov; 38(11):1127-1131. PubMed ID: 34729758
[TBL] [Abstract][Full Text] [Related]
50. Myocyte enhancer factor 2C and its directly-interacting proteins: A review.
Dong C; Yang XZ; Zhang CY; Liu YY; Zhou RB; Cheng QD; Yan EK; Yin DC
Prog Biophys Mol Biol; 2017 Jul; 126():22-30. PubMed ID: 28163053
[TBL] [Abstract][Full Text] [Related]
51. Myocyte-specific enhancer binding factor 2C expression in human brain development.
Leifer D; Golden J; Kowall NW
Neuroscience; 1994 Dec; 63(4):1067-79. PubMed ID: 7700509
[TBL] [Abstract][Full Text] [Related]
52. Further Clinical Delineation of the MEF2C Haploinsufficiency Syndrome: Report on New Cases and Literature Review of Severe Neurodevelopmental Disorders Presenting with Seizures, Absent Speech, and Involuntary Movements.
Vrečar I; Innes J; Jones EA; Kingston H; Reardon W; Kerr B; Clayton-Smith J; Douzgou S
J Pediatr Genet; 2017 Sep; 6(3):129-141. PubMed ID: 28794905
[TBL] [Abstract][Full Text] [Related]
53. The MEF2C gene-microdeletion 5q14.3 dilemma and three axioms for molecular syndromology.
Wilson GN
Am J Med Genet A; 2013 Apr; 161A(4):916-7. PubMed ID: 23495102
[No Abstract] [Full Text] [Related]
54. The MEF2C-Related and 5q14.3q15 Microdeletion Syndrome.
Zweier M; Rauch A
Mol Syndromol; 2012 Apr; 2(3-5):164-170. PubMed ID: 22670137
[TBL] [Abstract][Full Text] [Related]
55. An intellectually disabled patient with the 5q14.3q15 microdeletion syndrome associated with an apparently de novo t(2;5)(q13;q14).
Toral-López J; Buentello-Volante B; Balderas-Minor MM; Amezcua-Herrera C; Valdes-Miranda JM; González-Huerta LM; Gudiño M; Cuevas-Covarrubias SA; Zenteno JC
Am J Med Genet A; 2012 Apr; 158A(4):942-6. PubMed ID: 22419405
[No Abstract] [Full Text] [Related]
56. De novo 5q14.3 translocation 121.5-kb upstream of MEF2C in a patient with severe intellectual disability and early-onset epileptic encephalopathy.
Saitsu H; Igarashi N; Kato M; Okada I; Kosho T; Shimokawa O; Sasaki Y; Nishiyama K; Tsurusaki Y; Doi H; Miyake N; Harada N; Hayasaka K; Matasumoto N
Am J Med Genet A; 2011 Nov; 155A(11):2879-84. PubMed ID: 21990267
[TBL] [Abstract][Full Text] [Related]
57. MEF2C-Related 5q14.3 Microdeletion Syndrome Detected by Array CGH: A Case Report.
Shim JS; Min K; Lee SH; Park JE; Park SH; Kim M; Shim SH
Ann Rehabil Med; 2015 Jun; 39(3):482-7. PubMed ID: 26161356
[TBL] [Abstract][Full Text] [Related]
58. Genes influenced by MEF2C contribute to neurodevelopmental disease via gene expression changes that affect multiple types of cortical excitatory neurons.
Cosgrove D; Whitton L; Fahey L; Ó Broin P; Donohoe G; Morris DW
Hum Mol Genet; 2021 May; 30(11):961-970. PubMed ID: 32975584
[TBL] [Abstract][Full Text] [Related]
59. Bone marrow-induced Mef2c deficiency delays B-cell development and alters the expression of key B-cell regulatory proteins.
Debnath I; Roundy KM; Pioli PD; Weis JJ; Weis JH
Int Immunol; 2013 Feb; 25(2):99-115. PubMed ID: 23087187
[TBL] [Abstract][Full Text] [Related]
60. Transcriptional and functional consequences of alterations to MEF2C and its topological organization in neuronal models.
Mohajeri K; Yadav R; D'haene E; Boone PM; Erdin S; Gao D; Moyses-Oliveira M; Bhavsar R; Currall BB; O'Keefe K; Burt ND; Lowther C; Lucente D; Salani M; Larson M; Redin C; Dudchenko O; Aiden EL; Menten B; Tai DJC; Gusella JF; Vergult S; Talkowski ME
Am J Hum Genet; 2022 Nov; 109(11):2049-2067. PubMed ID: 36283406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
